Literature DB >> 15855537

Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.

Hiep N'Guyen Trong1, Anne-Laure Prunier, Roland Leclercq.   

Abstract

Over 124 methicillin-susceptible Staphylococcus aureus 0/74 fluoroquinolone-susceptible versus 5/50 fluoroquinolone-resistant isolates were hypermutable. Hypermutable isolates combined mutations in gyrA, parC, and/or parE genes. One strain had a large deletion of the mutator mutS and mutL genes. No relevant mutation in mutS and mutL genes was found in the other isolates.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15855537      PMCID： PMC1087674          DOI： 10.1128/AAC.49.5.2098-2101.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Mutator bacteria as a risk factor in treatment of infectious diseases.

Authors:  Antoine Giraud; Ivan Matic; Miroslav Radman; Michel Fons; François Taddei
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 2.  Molecular mechanisms of DNA mismatch repair.

Authors:  P Hsieh
Journal:  Mutat Res       Date:  2001-07-12       Impact factor: 2.433

Review 3.  The role of mutators in the emergence of antibiotic-resistant bacteria.

Authors:  Ian Chopra; Alexander J O'Neill; Keith Miller
Journal:  Drug Resist Updat       Date:  2003-06       Impact factor: 18.500

4.  High frequency of mutator strains among human uropathogenic Escherichia coli isolates.

Authors:  Erick Denamur; Stéphane Bonacorsi; Antoine Giraud; Patrick Duriez; Farida Hilali; Christine Amorin; Edouard Bingen; Antoine Andremont; Bertrand Picard; François Taddei; Ivan Matic
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

5.  Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair.

Authors:  J H Miller
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

6.  Crystal structure and ATPase activity of MutL: implications for DNA repair and mutagenesis.

Authors:  C Ban; W Yang
Journal:  Cell       Date:  1998-11-13       Impact factor: 41.582

7.  Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair.

Authors:  C Ban; M Junop; W Yang
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

Review 8.  Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance.

Authors:  F-J Schmitz; P G Higgins; S Mayer; A C Fluit; A Dalhoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-09-07       Impact factor: 3.267

9.  Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low.

Authors:  Alexander J O'Neill; Ian Chopra
Journal:  J Antimicrob Chemother       Date:  2002-08       Impact factor: 5.790

10.  Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

Authors:  Patricia Komp Lindgren; Asa Karlsson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191
View more
  21 in total

1.  Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability.

Authors:  María Pérez-Vázquez; Federico Román; Silvia García-Cobos; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

2.  Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus.

Authors:  Lili Rosana Mesak; Vivian Miao; Julian Davies
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

3.  Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections.

Authors:  Jeffrey Fernandez; Jamese J Hilliard; Brian J Morrow; John L Melton; Robert K Flamm; Alfred M Barron; A Simon Lynch
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

Review 4.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Association of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea.

Authors:  Yee Gyung Kwak; Que Chi Truong-Bolduc; Hong Bin Kim; Kyoung-Ho Song; Eu Suk Kim; David C Hooper
Journal:  J Antimicrob Chemother       Date:  2013-08-08       Impact factor: 5.790

6.  The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.

Authors:  Silke Besier; Johannes Zander; Barbara C Kahl; Peter Kraiczy; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

7.  The fitness cost of mismatch repair mutators in Saccharomyces cerevisiae: partitioning the mutational load.

Authors:  Benjamin Galeota-Sprung; Breanna Guindon; Paul Sniegowski
Journal:  Heredity (Edinb)       Date:  2019-09-12       Impact factor: 3.821

8.  Azithromycin and Ciprofloxacin Can Promote Antibiotic Resistance in Biosolids and Biosolids-Amended Soils.

Authors:  Harmanpreet Sidhu; Hee-Sung Bae; Andrew Ogram; George O'Connor; Fahong Yu
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

9.  Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus.

Authors:  Paul R McAdam; Kate E Templeton; Giles F Edwards; Matthew T G Holden; Edward J Feil; David M Aanensen; Hiba J A Bargawi; Brian G Spratt; Stephen D Bentley; Julian Parkhill; Mark C Enright; Anne Holmes; E Kirsty Girvan; Paul A Godfrey; Michael Feldgarden; Angela M Kearns; Andrew Rambaut; D Ashley Robinson; J Ross Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

10.  Targeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strains.

Authors:  Konrad B Plata; Sarah Riosa; Christopher R Singh; Roberto R Rosato; Adriana E Rosato
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.